Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis

Catherine H. Lee, Adam J. Mamelak, Eric C. Vonderheid

Research output: Contribution to journalArticle

Abstract

Background: Hypereosinophilic syndrome (HES) is a heterogeneous group of disorders characterized by a sustained eosinophilia leading to end organ dysfunction. The lymphoproliferative variant of HES is thought to be mediated by an underlying hematologic process that drives eosinophil production through specific cytokines. Eosinophilia is also recognized as a poor prognostic factor in cutaneous T-cell lymphoma (CTCL) in which neoplastic T cells may produce eosinophilopoietic cytokines. Objective: We report a case of HES with cardiac involvement that developed in the context of erythrodermic mycosis fungoides, discuss the possible relationship between these diseases, and speculate on the role that eosinophils might play as a prognostic factor in CTCL. Methods: Case report and review of the literature. Results: CTCL may beadded to the group of lymphoproliferative disorders associated with HES. Conclusion: A patient with erythroderma and concomitant diagnosis of "idiopathic" HES may warrant further investigation for CTCL.

Original languageEnglish (US)
Pages (from-to)1198-1204
Number of pages7
JournalInternational Journal of Dermatology
Volume46
Issue number11
DOIs
StatePublished - Nov 2007

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis'. Together they form a unique fingerprint.

  • Cite this